Ceros Capital Markets
VC Fund
Miami, United States
Ceros Capital Markets is a global investment platform for companies in the medical device, robotics, and digital health space. The firm is headquartered in Miami, Florida, United States.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Ceros Capital Markets invests in
Stages Ceros Capital Markets invests in
Countries Ceros Capital Markets invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
Investment Focus
Industry
- Medical 3 (60%)
- Health Care 3 (60%)
- Medical Device 3 (60%)
- Biotechnology 1 (20%)
- Manufacturing 1 (20%)
Stage
- Series A 2 (40%)
- Series B 2 (40%)
- Series D 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mark Goldwasser
CEO
|
CEO | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery. | $15M / Series A / Jul 18, 2022 | |
|
|
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions forpotential cancer in seconds. | $10M / Series B / Jun 15, 2022 | |
|
|
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions forpotential cancer in seconds. | $10M / Series A / Jun 15, 2022 | |
|
|
Pristine Surgical has developed a first-of-its-kind, single-use visualization platform for surgical and diagnostic rigid endoscopic procedures by combining state-of-the-art, high-definition digital imaging with advanced LED lighting, artificial intelligence and cloud-based software. Its single-use arthroscopes and laparoscopes are delivered in a100% sterile kit, and together with its cloud-based workflow reduction software, promises to reduce cost, reduce risk and increase efficiency for over 23 million procedures per year. | $15M / Series D / Mar 02, 2022 | |
|
|
Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists. They work with clinical dermatology practices to digitize the pathology workflow, which is helping to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. They also deliveran intuitive and easy-to-implement digital pathology solution that includes access to top-tier Dermatopathologists.It was founded in 2017 and is based in Salt Lake City, Utah. | $25M / Series B / Nov 16, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ceros Capital Markets invest in?
Ceros Capital Markets invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ceros Capital Markets?
Public channels for Ceros Capital Markets include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ceros Capital Markets?
The team at Ceros Capital Markets includes Mark Goldwasser (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!